Literature DB >> 11723051

Intrinsic defects in the T-cell lineage results in natural killer T-cell deficiency and the development of diabetes in the nonobese diabetic mouse.

Y Yang1, M Bao, J W Yoon.   

Abstract

T-cell-mediated autoimmune diabetes in nonobese diabetic (NOD) mice is closely associated with natural killer T (NKT)-cell deficiency. To determine whether intrinsic defects of the T-cell lineage contribute to the pathogenesis of the disease and NKT cell deficiency, we reconstituted the T-cell compartment in NOD.scid or BALB.scid mice with T-cells from NOD, nonobese diabetes-resistant (NOR), or AKR thymic precursor cells and examined the development of the NKT cell population. NKT cells developed well from AKR thymic precursor cells but not from other precursor cells in both recipient strains. Insulitis and diabetes developed only in the NOD.scid recipients of NOD or NOR precursor cells. When thymic precursor cells of beta2-microglobulin gene-deficient AKR mice, which have a deficient NKT population, were introduced into NOD.scid recipients, both CD4(+) and CD8(+) T-cell populations developed and the recipient mice developed insulitis and diabetes. We conclude that NKT cells originate from a T-cell-committed thymic precursor population and that the deficiency in the NKT cell population in NOD mice results from intrinsic defects within the T-cell lineage and plays a major role in the development of autoimmune diabetes in the presence of both the NOD thymus and antigen-presenting cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11723051     DOI: 10.2337/diabetes.50.12.2691

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  9 in total

1.  New autoimmune genes and the pathogenesis of type 1 diabetes.

Authors:  Lars Hornum; Helle Markholst
Journal:  Curr Diab Rep       Date:  2004-04       Impact factor: 4.810

2.  The glycolipid exoantigen derived from Chlamydia muridarum activates invariant natural killer T cells.

Authors:  Ying Peng; Lei Zhao; Sudhanshu Shekhar; Lu Liu; Hong Wang; Qiang Chen; Xiaoling Gao; Xi Yang; Weiming Zhao
Journal:  Cell Mol Immunol       Date:  2012-06-25       Impact factor: 11.530

Review 3.  Role of regulatory invariant CD1d-restricted natural killer T-cells in protection against type 1 diabetes.

Authors:  Shabbir Hussain; Melany Wagner; Dalam Ly; Terry L Delovitch
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 4.  Natural killer T cells and atherosclerosis: form and function meet pathogenesis.

Authors:  Nicole A Braun; Roman Covarrubias; Amy S Major
Journal:  J Innate Immun       Date:  2010-03-17       Impact factor: 7.349

Review 5.  T cells in atherosclerosis.

Authors:  Kevin Tse; Harley Tse; John Sidney; Alex Sette; Klaus Ley
Journal:  Int Immunol       Date:  2013-11       Impact factor: 4.823

6.  Induction of active tolerance and involvement of CD1d-restricted natural killer T cells in anti-CD3 F(ab')2 treatment-reversed new-onset diabetes in nonobese diabetic mice.

Authors:  Guojiang Chen; Gencheng Han; Jianan Wang; Renxi Wang; Ruonan Xu; Beifen Shen; Jiahua Qian; Yan Li
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

7.  Widespread natural variation in murine natural killer T-cell number and function.

Authors:  Stacia L Rymarchyk; Hayden Lowenstein; Jana Mayette; Samantha R Foster; David E Damby; Isaac W Howe; Idil Aktan; Russell E Meyer; Matthew E Poynter; Jonathan E Boyson
Journal:  Immunology       Date:  2008-04-26       Impact factor: 7.397

8.  CD1d-restricted natural killer T cells are potent targets for human immunodeficiency virus infection.

Authors:  Richardson Fleuridor; Brian Wilson; Runhua Hou; Alan Landay; Harold Kessler; Lena Al-Harthi
Journal:  Immunology       Date:  2003-01       Impact factor: 7.397

Review 9.  Dissecting autoimmune diabetes through genetic manipulation of non-obese diabetic mice.

Authors:  Y Yang; P Santamaria
Journal:  Diabetologia       Date:  2003-10-28       Impact factor: 10.122

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.